Abstract
BackgroundAnti-citrullinated protein antibodies (ACPA) aggravate inflammation, activate osteoclasts, and accelerate bone resorption in RA patients.1 We previously reported that a decrease in ACPA was observed during 52 weeks of TCZ...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
